期刊文献+

134例药物性皮炎调查报告 被引量:2

Investigation of 134 reports of drug dermatitis in our hospital
原文传递
导出
摘要 目的:了解药物性皮炎发生的特点,为临床合理用药提供参考。方法:回顾性调查2012~2013年我院临床上报的134例药物性皮炎的不良反应(ADR)报告,建立 Excel 表格,分别统计患者的一般情况、用药情况、药物性皮炎临床表现、处置等项目并作分析。结果:发生药物性皮炎患者中男性59例,女性75例,平均年龄(37.7±1.75)岁。发现致敏药物为喹诺酮类、头孢菌素类、青霉素类、中成药及其提取物类、生物制剂类、解热镇痛类等。引起药物性皮炎主要给药途径为静脉滴注。结论:抗生素的广泛使用和静脉注射的给药方式是引起皮疹的主要原因。 Objective:To analyze the characteristic and rules of drug dermatitis to provide reference for clinical rational drug use. Methods:In the retrospective review,a retrospective analysis of 134 case of drug dermatitis in our hospital was made from 2012 to 2013. The Excel form including the general condition of patients was established to analyze their medication,drug dermatitis,clinical manifestation,treatment of adverse reaction and so on. Results:The drug dermatitis occurred in 59 men and 75 women with an average age of 37. 7 years. Drugs sensitized were quinolones,cephalosporins,penicillins,TCM and their extracts,type of biological agents and so on. Drug dermatitis were caused by intravenous drip. Conclusion:The drug dermatitis main reason is widely used antibiotic and In-travenous injection.
出处 《中国药物滥用防治杂志》 CAS 2015年第2期88-90,共3页 Chinese Journal of Drug Abuse Prevention and Treatment
关键词 药物性皮炎 药物不良反应 调查报告 合理用药 drug dermatitis ADR analysis rational drug use
  • 相关文献

参考文献5

  • 1卫生部,国家食品药品监督管理局.不良反应报告和监测箭圳办法[S].2004.
  • 2刘芝红,吴金萍.抗生素药疹200例临床分析[J].中外医疗,2010,29(21):44-44. 被引量:2
  • 3卫生部,国家中医药管理局.抗菌药物临床应用指导原则[S].2004:8~19
  • 4卫生部合理用药专家委员会.中国医师药师临床用药指南[M].重庆:重庆出版集团重庆出版社,2009:700-701.
  • 5汪琳,邱晓燕.119例重症药疹的回顾性分析[J].中国临床药理学与治疗学,2014,19(8):885-889. 被引量:9

二级参考文献17

  • 1李佳玟,郭毓文,王俐.重型药疹55例临床分析[J].中国麻风皮肤病杂志,2004,20(4):356-356. 被引量:6
  • 2何志新,甘戈,王宝玺.539例药疹临床分析[J].中华皮肤科杂志,2006,39(12):703-705. 被引量:40
  • 3马川,李邻峰.45例重症药疹患者发病情况分析[J].中国麻风皮肤病杂志,2007,23(1):37-39. 被引量:12
  • 4张学军.皮肤病学[M].6版.北京:人民卫生出版社,2005:113-114.
  • 5Huang HY,Luo XQ,Chan LS,et al. Cutaneous ad- verse drug reactions in a hospital-based Chinese population[J]. Clin Exp Dermatol,2010,35(6) :1-6.
  • 6Sushma M, Noel MV, Ritika MC, et al. Cutaneous adverse drug reactions:a 9 year study from a South Indian Hospital[J]. Pharmacoepidemiol Drug Saf, 2005,14(8) : 567-570.
  • 7Ozeki T, Mushiroda T, Yowang A, et al. Genome- wide association study identifies HLA A * 3101 al- lele as a genetic risk factor for carbamazepine-in- duced cutaneous adverse drug reactions in Japanese population[J]. Hum Mol Genet, 2011,20 ( 5 ) : 1034- 1041.
  • 8Wu XT,Hu FY,An DM,et al. Association between carbamazepine-induced cutaneous adverse drug reac- tions and the HLA-B * 1502 allele among patients in central China[J]. Epilepsy Behav, 2010,19 (3): 405- 408.
  • 9Ozeki T, Mushiroda T, Yowang A, et al. Genome- wide association study identifies HLA-A * 3101 al- lele as a genetic risk factor for carbamazepine-in- duced cutaneous adverse drug reactions in Japanese population[J]. Hum Mol Genet, 2011,20 ( 5 ) : 1034- 1041.
  • 10Arndt C, Hawkins D, Anderson JR, et al. Age is a risk factor for chemotherapy - induced hepatopathy with vincristine, dactinomycin, and cyclophospha- mide [J] . J Clin Oncol,2004,22(10): 1894-1901.

共引文献500

同被引文献15

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部